Overcoming resistance to erbb pathway inhibitors
US-2015231238-A1 · Aug 20, 2015 · US
This page is not indexed by search engines while we improve data quality.
Mcdonagh Charlotte patents
Mcdonagh Charlotte holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 0 |
| First publication | Jan 6, 2015 |
| Latest publication | Aug 20, 2015 |
Filing trend
Year-over-year patent counts for this assignee.
Not enough yearly data to assess filing trend yet.
| Year | Patents |
|---|---|
| 2015 | 3 |
| Year | Patents |
|---|---|
| 2015 | 3 |
Recent patents
Latest publications where this party is an assignee.
CD19 binding agents and uses thereof
US-9073993-B2 · Jul 7, 2015 · US
Human serum albumin linkers and conjugates thereof
US-8927694-B2 · Jan 6, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Overcoming resistance to erbb pathway inhibitors
US-2015231238-A1 · Aug 20, 2015 · US
CD19 binding agents and uses thereof
US-9073993-B2 · Jul 7, 2015 · US
Human serum albumin linkers and conjugates thereof
US-8927694-B2 · Jan 6, 2015 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K2039/505 | 3 |
| A61P35/00 | 3 |
| C07K2317/24 | 2 |
| A61K39/395 | 2 |
| C07K2317/31 | 2 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 3 |
| Cross-Sectional Technologies | 1 |